Differential profiles of cholinesterase inhibition and neurobehavioral effects in rats exposed to fenamiphos or profenofos

Neurotoxicology and Teratology

Volumn 26, Issue 3, 2004, Pages 407-415

  McDaniel, Katherine L ^a   Moser, Virginia C ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cholinesterase; Fenamiphos; Neurobehavior; Organophosphates; Profenofos

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; FENAMIPHOS; METHYLSCOPOLAMINE; ORGANOPHOSPHATE PESTICIDE; PROFENOFOS; SCOPOLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN REGION; CEREBELLUM; CHOLINESTERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DISSECTION; DOSE RESPONSE; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHESIS; LETHAL DOSE; MALE; MEDULLA OBLONGATA; NONHUMAN; PONS; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; MALE; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, LONG-EVANS; SALIVATION; SCOPOLAMINE; THIOPHOSPHORIC ACID ESTERS; TISSUE DISTRIBUTION; TREMOR;

EID: 2042502378     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2004.01.001     Document Type: Article

References (47)

1. Astroff A.B., Young A.D. The relationship between maternal and fetal effects following maternal organophosphate exposure during gestation in the rat. Toxicol. Ind. Health. 14(6):1998;869-889
2. Bignami G., Rosic N., Michalek H., Milosevic M., Gatti G.L. Behavioral toxicity of anticholinesterase agents: methodological, neurochemical, and neuropsychological aspects. Weiss B., Laties V.G. Behavioral Toxicology. 1975;155-216 Plenum, New York
3. Bobba R., Venkataraman B.V., Pais P., Joseph T. Correlation between the severity of symptoms in organophosphorus poisoning and cholinesterase activity (RBC and plasma) in humans. Indian J. Physiol. Pharmacol. 40(3):1996;249-252
4. Brezenoff H.E., McGee J., Hymowitz N. Effect of soman on schedule-controlled behavior and brain acetylcholinesterase in rats. Life Sci. 37:1985;2421-2430
5. Chaudhuri J., Chakraborti T.K., Chanda S., Pope C.N. Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos. J. Biochem. Toxicol. 8(4):1993;207-216
6. Creason J.P. Data evaluation and statistical analysis of functional observational battery data using a linear models approach. J. Amer. Coll. Toxicol. 8:1989;157-169
7. D'Mello G.D. Behavioral toxicity of anticholinesterases in humans and animals - A review. Human Exp. Toxicol. 12(1):1993;3-7
8. Glickman A.H., Wing K.D., Casida J.E. Profenofos insecticide bioactivation in relation to antidote action and the stereospecificity of acetylcholinesterase inhibition, reactivation, and aging. Toxicol. Appl. Pharmacol. 73:1984;16-22
9. 3H] dopa in various regions of the brain. J. Neurochem. 13(8):1966;655-669
10. Gordon C.J., Grantham T.A. Effect of central and peripheral cholinergic antagonists on chlorpyrifos-induced changes in body temperature in the rat. Toxicology. 142:1999;15-28
11. Gupta R.C., Patterson G.T., Dettbarn W.-D. Biochemical and histochemical alterations following acute soman intoxication in the rat. Toxicol. Appl. Pharmacol. 87:1987;393-402
12. Gupta R.C., Patterson G.T., Dettbarn W.-D. Acute tabun toxicity; biochemical and histochemical consequences in brain and skeletal muscles of rat. Toxicology. 46:1987;329-341
13. Howerton T.C., Murphy M.R., Miller S.A., Hartgraves S.L. Differential sensitivity of CNS regions to acetylcholinesterase inhibition following chronic low-dose soman treatment in the rat. Psychopharmacology. 105:1991;400-406
14. Jimmerson V.R., Shih T.-M., Mailman R.B. Variability in soman toxicity in the rat: Correlation with biochemical and behavioral measures. Toxicology. 7:1989;241-254
15. Johnson C.D., Russell R.L. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64:1975;229-238
16. Katz L.S., Marquis J.K. Modulation of central muscarinic receptor binding in vitro by ultralow levels of the organophosphate paraoxon. Toxicol. Appl. Pharmacol. 101:1989;114-123
17. Khan W.A., Dechkovskaia A.M., Herrick E.A., Jones K.H., Abou-Donia M.B. Acute sarin exposure causes differential regulation of choline acetyltransferase, acetylcholinesterase, and acetylcholine receptors in the central nervous system of the rat. Toxicol. Sci. 57(1):2000;112-120
18. Kurtz J. Dissociated behavioral and cholinesterase decrements following malathion exposure. Toxicol. Appl. Pharmacol. 42:1977;589-594
19. Lynch M.R., Rice M.A., Robinson S.E. Dissociation of locomotor depression and ChE activity after DFP, soman and sarin. Pharmacol. Biochem. Behav. 24:1986;941-947
20. Ma T., Kramer R.E., Baker R.C., Fan L.W., Ho I.K. Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats. J. Neurosci. Res. 71(1):2003;138-145
21. Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 5:1993;51-66
22. McDaniel K.L., Moser V.C. Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin. Neurotoxicol. Teratol. 15:1993;71-83
23. Misulis K.E., Clinton M.E., Dettbarn W.-D., Gupta R.C. Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase. Toxicol. Appl. Pharmacol. 89:1987;391-398
24. Moretto A. Experimental and clinical toxicology of anticholinesterase agents. Toxicol. Lett. 102-103:1998;509-513
25. Moser V.C. Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Neurotoxicol. Teratol. 17(6):1995;617-625
26. Moser V.C. Comparison of aldicarb and methamidophos neurotoxicity at different ages in the rat: Behavioral and biochemical parameters. Toxicol. Appl. Pharmacol. 157(2):1999;94-106
27. Moser V.C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 149(1):1998;107-119
28. Moser V.C., McCormick J.P., Creason J.P., MacPhail R.C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 11:1988;189-206
29. Moss D.E., Rodriguez L.A., McMaster S.B. Comparative behavioral effects of CNS cholinesterase inhibitors. Pharmacol. Biochem. Behav. 22:1985;479-482
30. Nostrandt A.C., Padilla S., Moser V.C. The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat. Pharmacol. Biochem. Behav. 58:1997;15-23
31. Pope C.N. Organophosphorus pesticides: Do they all have the same mechanism of toxicity? J. Toxicol. Environ. Health, Part B. Crit. Rev. 2:1999;161-181
32. Pope C.N., Chaudhuri J., Chakraborti T.K. Organophosphate-sensitive cholinergic receptors. Quinn D.M., Balasubramanian A.S., Doctor B.P., Taylor P. Enzymes of the Cholinesterase Family. 1995;305-312 Plenum, New York
33. Quistad G.B., Casida J.E. Sensitivity of blood-clotting factors and digestive enzymes to inhibition by organophosphorus pesticides. J. Biochem. Mol. Toxicol. 14(1):2000;51-56
34. Reiter L.W. Chemical exposures and animal toxicity: utility of the figure-eight maze. Hayes A.W., Schell R.C., Miya T.S. The Science and Practice of Toxicology. 1983;73-84 Elsevier, New York
35. Salama A.K., Radwan M.A., El-Shahawi F.I. Pharmacokinetic profile and anticholinesterase properties of phenamiphos in male rats. J. Environ. Sci. Health, Part B, Pestic. Food Contam. Agric. Wastes. 27(3):1992;307-323
36. Santhoshkumar P., Karanth S., Shivanandappa T. Neurotoxicity and pattern of acetylcholinesterase inhibition in the brain regions of rat by bromophos and ethylbromophos. Fundam. Appl. Toxicol. 32:1996;23-30
37. SAS Institute SAS/STAT User's Guide, Version 6. 1990;SAS Institute, Cary, NC
38. Sharma R.P., Shupe J.L., Potter J.R. Tissue cholinesterase inhibition by 2-carbomethoxy-1-methylvinyl dimethyl phosphate (mevinphos). Toxicol. Appl. Pharmacol. 24:1973;645-652
39. Sivam S.P., Norris J.C., Lim D.K., Hoskins B., Ho I.K. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum. J. Neurochem. 40(5):1983;1414-1422
40. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150(1):1985;76-85
41. Sun L., Ma T.G., Liu Y.G. Effects of phenamiphos on muscarinic acetylcholine receptor in the brain synaptosome in rats and its mechanism. J. Tongji Med. Univ. 14(2):1994;89-93
42. Taylor P. Anticholinesterase agents. Gilman A.G., Goodman L.S., Rall T.W., Murad F. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 7th edition:1985;110-129 MacMillan, New York
43. US EPA, Human health risk assessment: Fenamiphos, 1999a, http://www.epa.gov/pesticides/op/fenamiphos/hedsep99.pdf.
44. US EPA, Executive summary for profenofos, 1999b, http://www.epa.gov/ pesticides/op/profenofos/profbrief.htm.
45. US EPA, The HED chapter of the reregistration eligibility decision document (RED) for profenofos, 1999c, http://www.epa.gov/pesticides/op/ profenofos/prohed.pdf.
46. US EPA, Overview of fenamiphos risk assessment, 2003, http://www.epa.gov/pesticides/op/fenamiphos/overview.htm.
47. Weiner N. Atropine, scopolamine, and related antimuscarinic drugs. Gilman A.G., Goodman L.S., Rall T.W., Murad F. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 7th edition:1985;130-144 MacMillan, New York